Mohammad AskarPublic working copy · medical review pending

Eyelid tumours · 058

Eyelid tumours: diagnosis, clearance and reconstruction

Establish the lesion and its extent, then plan tumour control and protection of the eye together.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Tumour type, margin assessment and functional defect guide treatment.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Precursors and risk context

Actinic keratosis is UV-related keratinocytic dysplasia with potential progression to squamous carcinoma, not automatically full-thickness carcinoma in situ. Albinism increases UV susceptibility; xeroderma pigmentosum is a genetic DNA-repair disorder with marked UV-related tumour risk. Identify the clinical context rather than equating all rough lesions with one stage. 1

Keratoacanthoma can grow rapidly with a central keratin crater and may regress, but it can be difficult to distinguish from invasive SCC. The original blood-supply/necrosis explanation for regression is unverified here and does not justify observation of a suspicious lid lesion without tissue assessment. 1

02Recognise malignant patterns

Basal cell carcinoma (BCC) is common among malignant lid tumours in many populations, often on the lower lid or medial canthus. It destroys locally and metastasises very rarely, not never. Squamous cell carcinoma (SCC) may invade nerves and orbit and spread regionally or distantly; perineural or intracranial extension is not its only route. 1 2

Sebaceous carcinoma may arise from meibomian or Zeis glands, often in the upper lid, with recurrent chalazion, unilateral blepharitis or pagetoid spread as clues. The original mortality around 10% is not a universally transferable prognosis without stage, cohort and follow-up. Deep or appropriately planned biopsy and pathological review matter when the clinical suspicion persists. 1 3

Melanoma includes lentigo maligna-associated, superficial spreading, nodular and amelanotic patterns. Determine Breslow thickness and other histological risk factors; a generic 2–4 mm excision margin is not definitive melanoma treatment. Kaposi sarcoma may appear red-purple and associates with HHV8; HIV-related disease is one context, not the only one. 1 4

03Plan biopsy and margins

Choose incisional or excisional biopsy according to size, suspected histology and the definitive plan; a separate diagnostic incision is not compulsory before every small excision. Preserve specimen orientation and document margin assessment. Mohs or other complete margin-controlled surgery can conserve tissue, especially in high-risk sites, but is not one universal method for every lid malignancy. 1 2 3 4

For BCC, the guideline distinguishes tumour-adapted conventional margins from complete microscopic control in high-risk or recurrent disease. Eyelid location requires protection of eye, closure and lacrimal apparatus, sometimes with staged excision before reconstruction. Follow-up must assess tumour recurrence and function rather than declaring cure from an apparently clear clinical edge. 1 2

04Restore both lamellae and blood supply

Anterior lamella is skin and orbicularis; posterior lamella provides tarsal support and conjunctival lining. The original <1/3, 1/3–1/2 and >1/2 size bands orient reconstruction but do not override lid laxity, location, age or defect depth. Direct pentagonal closure, cantholysis or a Tenzel flap, and more complex lamellar reconstruction are selected accordingly. 1 5

Free tarsoconjunctival tissue from the other lid or selected hard-palate mucosa can replace posterior tissue; amniotic membrane can support surface repair but is not a structural substitute for tarsus. A full-thickness skin graft or local flap restores anterior tissue, with a vascularised lamella supporting free graft survival. Hughes lower-lid and Cutler–Beard upper-lid procedures are staged lid-sharing options: temporary occlusion for weeks matters particularly for amblyopia risk in children. 1 5

Restore both lamellae and blood supply
Original full-thickness defect bandPossible approach and limits
<1/3 lid widthDirect pentagonal closure if tension and laxity permit
1/3–1/2 lid widthCantholysis or Tenzel recruitment as appropriate; location matters
>1/2 lid widthLamellar reconstruction, possibly staged; ensure vascular supply and ocular protection

05Nonsurgical and systemic options

Radiotherapy may suit selected inoperable cases, informed refusal of surgery or defined adjuvant indications. Discuss dry eye, cataract, retinopathy and more difficult reconstruction after recurrence; it is not risk-free. Cryotherapy is not a generic substitute for histologically controlled treatment of invasive disease. Topical or systemic chemotherapy is tumour-specific, not a blanket recommendation for all Kaposi or lid lesions. 1 2

Targeted agents or immunotherapy may be appropriate for selected advanced BCC or melanoma within multidisciplinary oncology care. Histology, extent, molecular context, prior treatment, patient goals and local availability determine selection; this chapter does not imply approval of every drug for every tumour or jurisdiction. 1 2 4

What are the main learning points?

Tumour type, margin assessment and functional defect guide treatment.

When is assessment urgent?

Rapid growth, ulceration, lash loss, bleeding, sensory change or a recurrent atypical chalazion needs prompt specialist assessment.

References and access status

  1. 1
    Immutable original export; original video attribution unchecked

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    AWMF S2k BCC, update 2023 version 9.0, PDF July 2024

    PDF text sections on metastasis, risk, surgery and eyelid management, printed pages 20 and 28–38 read; not the entire guideline.

  3. 3
    2019 evidence-based sebaceous carcinoma guideline

    Selected indexed primary guidance passages read on 2026-11-09; complete document and supplements not read.

  4. 4
    ESMO cutaneous melanoma guideline 2024/2025

    Selected indexed primary guidance passages read on 2026-11-09; complete document and supplements not read.

  5. 5
    2024 Eyelid Reconstruction surgical review

    Selected indexed operative review passages on both lamellae, Hughes and Cutler–Beard read; full article and original surgical series unread.

Original lecture link